Skip to main content
TipRanks
Go Ultimate75% OFF

Cryo-Cell International (CCEL) Stock Statistics & Valuation Metrics

57 Followers

Total Valuation

Cryo-Cell International has a market cap or net worth of $36.69M. The enterprise value is $38.46M.

Market Cap
$36.69M
Enterprise Value
$38.46M

Share Statistics

Cryo-Cell International has 8,062,650 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
8,062,650
Owned by Insiders
34.66%
Owned by Institutions
6.35%

Financial Efficiency

Cryo-Cell International’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.79%.

Return on Equity (ROE)
0.13
Return on Assets (ROA)
-0.04
Return on Invested Capital (ROIC)
10.79%
Return on Capital Employed (ROCE)
0.12
Revenue Per Employee
426.57K
Profits Per Employee
-32.83K
Employee Count
74
Asset Turnover
0.51
Inventory Turnover
18.04

Valuation Ratios

The current PE Ratio of Cryo-Cell International is -18.33. Cryo-Cell International’s PEG ratio is 0.05.

PE Ratio
-18.33
PS Ratio
1.06
PB Ratio
-2.02
Price to FCF
7.12
Price to Operating Cash Flow
6.73
PEG Ratio
0.05

Income Statement

In the last 12 months, Cryo-Cell International had revenue of 31.57M and earned -2.43M in profits. Earnings per share was -0.30.

Revenue
31.57M
Gross Profit
24.19M
Operating Income
4.84M
Pretax Income
-2.34M
Net Income
-2.43M
EBITDA
1.10M
Earnings Per Share (EPS)
-0.30

Cash Flow

In the last 12 months, operating cash flow was 4.92M and capital expenditures -268,871, giving a free cash flow of 4.65M billion.

Operating Cash Flow
4.92M
Free Cash Flow
4.65M
Free Cash Flow per Share
0.58

Dividends & Yields

Cryo-Cell International pays an annual dividend of $0.15, resulting in a dividend yield of ―

Dividend Per Share
$0.15
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
14.04%
Earnings Yield
-8.51%

Stock Price Statistics

Beta
0.13
52-Week Price Change
10.71%
50-Day Moving Average
4.47
200-Day Moving Average
3.77
Relative Strength Index (RSI)
51.09
Average Volume (3m)
13.69K

Important Dates

Cryo-Cell International upcoming earnings date is Feb 26, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 09, 2026
Next Earnings Date
Feb 26, 2027
Ex-Dividend Date
May 21, 2025

Financial Position

Cryo-Cell International as a current ratio of 0.59, with Debt / Equity ratio of -62.12%

Current Ratio
0.59
Quick Ratio
0.57
Debt to Market Cap
0.33
Net Debt to EBITDA
10.24
Interest Coverage Ratio
2.34

Taxes

In the past 12 months, Cryo-Cell International has paid 92.23K in taxes.

Income Tax
92.23K
Effective Tax Rate
-0.04

Enterprise Valuation

Cryo-Cell International EV to EBITDA ratio is 27.01, with an EV/FCF ratio of 6.94.

EV to Sales
1.04
EV to EBITDA
27.01
EV to Free Cash Flow
6.94
EV to Operating Cash Flow
6.56

Balance Sheet

Cryo-Cell International has $4.23M in cash and marketable securities with $577.20K in debt, giving a net cash position of $3.65M billion.

Cash & Marketable Securities
$4.23M
Total Debt
$577.20K
Net Cash
$3.65M
Net Cash Per Share
$0.45
Tangible Book Value Per Share
-$2.38

Margins

Gross margin is 77.95%, with operating margin of 0.61%, and net profit margin of -9.05%.

Gross Margin
77.95%
Operating Margin
0.61%
Pretax Margin
-6.13%
Net Profit Margin
-9.05%
EBITDA Margin
3.84%
EBIT Margin
-0.49%

Analyst Forecast

The average price target for Cryo-Cell International is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-1.96%
EPS Growth Forecast
-314.41%

Scores

Smart Score
5
AI Score
52